Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 3/20 | 0.33 |
| ▸ | PRSS2 | P07478 | 3/20 | 0.33 |
| ▸ | PRSS3 | P35030 | 3/20 | 0.33 |
| ▸ | ST14 | Q9Y5Y6 | 3/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
| ▸ | HPN | P05981 | 1/20 | 0.33 |
| ▸ | HGFAC | Q04756 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 2/20 | 0.30 |
| ▸ | PLG | P00747 | 1/20 | 0.30 |
| ▸ | AAK1 | Q2M2I8 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20194179 | 0.89 | F10 (0.44) | PRSS1PRSS2PRSS3ST14F10 | |
| SCHEMBL20194196 | 0.88 | AAK1 (0.32) | PRSS1PRSS2PRSS3ST14F10 | |
| SCHEMBL20194184 | 0.86 | F2 (0.36) | PRSS1PRSS2PRSS3ST14F2 | |
| SCHEMBL20194170 | 0.81 | F10 (0.37) | PRSS1PRSS2PRSS3ST14F10 | |
| SCHEMBL20194187 | 0.80 | CCR3 (0.34) | PRSS1PRSS2PRSS3ST14F10 | |
| SCHEMBL20194185 | 0.80 | F10 (0.46) | PRSS1PRSS2PRSS3ST14F10 | |
| SCHEMBL20194162 | 0.79 | F10 (0.34) | PRSS1PRSS2PRSS3ST14F10 | |
| SCHEMBL20194243 | 0.79 | F10 (0.42) | PRSS1PRSS2PRSS3ST14F10 | |
| SCHEMBL20194154 | 0.78 | AAK1 (0.46) | AAK1 | |
| SCHEMBL20194195 | 0.78 | F10 (0.36) | PRSS1PRSS2PRSS3ST14F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3054955-B1 | PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2018-05-30 | — | — | EP | disclosed |